{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:30:32Z","timestamp":1792740632102,"version":"4.5.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00842","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:16:37Z","timestamp":1591834597000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":97,"title":["Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development"],"prefix":"10.3389","volume":"11","author":[{"given":"Rebecca J.","family":"Loomis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume B. E.","family":"Stewart-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Tsybovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria T.","family":"Caringal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn M.","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Kueltzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.288.5470.1432","article-title":"Nipah virus: a recently emergent deadly paramyxovirus.","volume":"288","author":"Chua","year":"2000","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006367","article-title":"Henipavirus RNA in African bats.","volume":"4","author":"Drexler","year":"2009","journal-title":"PLoS One."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025256","article-title":"Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana. West Africa.","volume":"6","author":"Hayman","year":"2011","journal-title":"PLoS One."},{"key":"B4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.7701348","article-title":"A morbillivirus that caused fatal disease in horses and humans.","volume":"268","author":"Murray","year":"1995","journal-title":"Science."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9972","DOI":"10.1128\/jvi.74.21.9972-9979.2000","article-title":"The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae.","volume":"74","author":"Wang","year":"2000","journal-title":"J Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3201\/eid2006.131022","article-title":"Novel henipa-like virus, mojiang paramyxovirus, in rats, China, 2012.","volume":"20","author":"Wu","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1796","article-title":"Bats host major mammalian paramyxoviruses.","volume":"3","author":"Drexler","year":"2012","journal-title":"Nat Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0140-6736(99)04299-3","article-title":"Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia.","volume":"354","author":"Chua","year":"1999","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.20506\/rst.19.1.1202","article-title":"Nipah virus infection of pigs in peninsular Malaysia.","volume":"19","author":"Mohd","year":"2000","journal-title":"Rev Sci Tech."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1056\/NEJM200004273421701","article-title":"Clinical features of Nipah virus encephalitis among pig farmers in Malaysia.","volume":"342","author":"Goh","year":"2000","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/irdr.2018.01130","article-title":"Nipah virus disease: A rare and intractable disease.","volume":"8","author":"Banerjee","year":"2019","journal-title":"Intractable Rare Dis Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3201\/eid1202.051247","article-title":"Nipah virus-associated encephalitis outbreak, Siliguri, India.","volume":"12","author":"Chadha","year":"2006","journal-title":"Emerg Infect Dis."},{"key":"B13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2102.141433","article-title":"Outbreak of henipavirus infection, Philippines, 2014.","volume":"21","author":"Ching","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3201\/eid1110.050513","article-title":"Genetic characterization of Nipah virus, Bangladesh, 2004.","volume":"11","author":"Harcourt","year":"2005","journal-title":"Emerg Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3201\/eid1012.040701","article-title":"Nipah virus encephalitis reemergence, Bangladesh.","volume":"10","author":"Hsu","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/647951","article-title":"Transmission of human infection with Nipah virus.","volume":"49","author":"Luby","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B17","first-page":"117","article-title":"Nipah virus - the rising epidemic: a review.","volume":"27","author":"Ochani","year":"2019","journal-title":"Infez Med."},{"key":"B18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3201\/eid1705.100968","article-title":"Genomic characterization of Nipah virus, West Bengal, India.","volume":"17","author":"Arankalle","year":"2011","journal-title":"Emerg Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/infdis\/jiy612","article-title":"Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018.","volume":"219","author":"Arunkumar","year":"2019","journal-title":"J Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3201\/eid1307.061128","article-title":"Person-to-person transmission of Nipah virus in a Bangladeshi community.","volume":"13","author":"Gurley","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3201\/eid1508.081237","article-title":"Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007.","volume":"15","author":"Luby","year":"2009","journal-title":"Emerg Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-017-0233-9","article-title":"Global research trends of World Health Organization\u2019s top eight emerging pathogens.","volume":"13","author":"Sweileh","year":"2017","journal-title":"Global Health."},{"key":"B23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/B978-0-444-53488-0.00032-8","article-title":"Henipavirus encephalitis.","volume":"123","author":"Abdullah","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jcv.2008.08.007","article-title":"The emergence of Nipah virus, a highly pathogenic paramyxovirus.","volume":"43","author":"Lo","year":"2008","journal-title":"J Clin Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00705-012-1352-5","article-title":"The immune response to Nipah virus infection.","volume":"157","author":"Prescott","year":"2012","journal-title":"Arch Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/82_2012_205","article-title":"Clinical and pathological manifestations of human henipavirus infection.","volume":"359","author":"Wong","year":"2012","journal-title":"Curr Top Microbiol Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coviro.2016.12.003","article-title":"Nipah virus: transmission of a zoonotic paramyxovirus.","volume":"22","author":"Clayton","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1863-2378.2012.01501.x","article-title":"Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission.","volume":"60","author":"Clayton","year":"2013","journal-title":"Zoonoses Public Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3201\/eid2309.161922","article-title":"Convergence of humans, bats, trees, and culture in nipah virus transmission, Bangladesh.","volume":"23","author":"Gurley","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3201\/eid1012.040452","article-title":"Isolation and molecular identification of Nipah virus from pigs.","volume":"10","author":"AbuBakar","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01875-17","article-title":"Nipah virus infection.","volume":"56","author":"Ang","year":"2018","journal-title":"J Clin Microbiol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1386-6532(02)00268-8","article-title":"Nipah virus outbreak in Malaysia.","volume":"26","author":"Chua","year":"2003","journal-title":"J Clin Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s1286-4579(01)01384-3","article-title":"The natural history of Hendra and Nipah viruses.","volume":"3","author":"Field","year":"2001","journal-title":"Microbes Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/82_2012_208","article-title":"Animal challenge models of henipavirus infection and pathogenesis.","volume":"359","author":"Geisbert","year":"2012","journal-title":"Curr Top Microbiol Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tvjl.2017.12.024","article-title":"Domesticated animals as hosts of henipaviruses and filoviruses: a systematic review.","volume":"233","author":"Glennon","year":"2018","journal-title":"Vet J."},{"key":"B36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3201\/eid0703.017312","article-title":"Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia.","volume":"7","author":"Yob","year":"2001","journal-title":"Emerg Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00549","article-title":"Infectious disease threats in the twenty-first century: strengthening the global response.","volume":"10","author":"Bloom","year":"2019","journal-title":"Front Immunol."},{"key":"B38","first-page":"p.1340","article-title":"Paramyxoviridae: THE viruses and their replication.","author":"Lamb","year":"1996","journal-title":"Fundamental virology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/viro.2002.1418","article-title":"Functional properties of the fusion and attachment glycoproteins of Nipah virus.","volume":"296","author":"Tamin","year":"2002","journal-title":"Virology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4614-7651-1_6","article-title":"Paramyxovirus entry.","volume":"790","author":"Bossart","year":"2013","journal-title":"Adv Exp Med Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.virol.2005.09.007","article-title":"Paramyxovirus membrane fusion: lessons from the F and HN atomic structures.","volume":"344","author":"Lamb","year":"2006","journal-title":"Virology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1111\/j.1742-4658.2009.07401.x","article-title":"Viral entry mechanisms: the increasing diversity of paramyxovirus entry.","volume":"276","author":"Smith","year":"2009","journal-title":"FEBS J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s1286-4579(01)01381-8","article-title":"Molecular biology of Hendra and Nipah viruses.","volume":"3","author":"Wang","year":"2001","journal-title":"Microbes Infect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1128\/JVI.01318-12","article-title":"Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins.","volume":"86","author":"Chan","year":"2012","journal-title":"J Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"12265","DOI":"10.1073\/pnas.1811980115","article-title":"Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.","volume":"115","author":"Stewart-Jones","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1073\/pnas.1523303113","article-title":"Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form.","volume":"113","author":"Wong","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005322","article-title":"Crystal Structure of the pre-fusion nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly.","volume":"11","author":"Xu","year":"2015","journal-title":"PLoS Pathog."},{"key":"B48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.","volume":"342","author":"McLellan","year":"2013","journal-title":"Science."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody.","volume":"340","author":"McLellan","year":"2013","journal-title":"Science."},{"key":"B50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A proof of concept for structure-based vaccine design targeting RSV in humans.","volume":"365","author":"Crank","year":"2019","journal-title":"Science."},{"key":"B51","doi-asserted-by":"publisher","first-page":"10652","DOI":"10.1073\/pnas.0504887102","article-title":"Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.","volume":"102","author":"Bonaparte","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","doi-asserted-by":"publisher","first-page":"11186","DOI":"10.1128\/jvi.76.22.11186-11198.2002","article-title":"Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins.","volume":"76","author":"Bossart","year":"2002","journal-title":"J Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nsmb.1435","article-title":"Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.","volume":"15","author":"Bowden","year":"2008","journal-title":"Nat Struct Mol Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature03838","article-title":"EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus.","volume":"436","author":"Negrete","year":"2005","journal-title":"Nature."},{"key":"B55","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcdb.2011.12.005","article-title":"Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.","volume":"23","author":"Xu","year":"2012","journal-title":"Semin Cell Dev Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1073\/pnas.0804797105","article-title":"Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3.","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B57","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1128\/JVI.79.11.6690-6702.2005","article-title":"Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.","volume":"79","author":"Bossart","year":"2005","journal-title":"J Virol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1016\/j.vaccine.2011.06.015","article-title":"A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.","volume":"29","author":"Pallister","year":"2011","journal-title":"Vaccine."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-237","article-title":"Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.","volume":"10","author":"Pallister","year":"2013","journal-title":"Virol J."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004241","article-title":"A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.","volume":"4","author":"Bossart","year":"2012","journal-title":"Sci Transl Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1128\/JVI.00005-14","article-title":"A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.","volume":"88","author":"Mire","year":"2014","journal-title":"J Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3201\/eid2003.131159","article-title":"Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.","volume":"20","author":"Middleton","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/v4020280","article-title":"Henipavirus mediated membrane fusion, virus entry and targeted therapeutics.","volume":"4","author":"Steffen","year":"2012","journal-title":"Viruses."},{"key":"B64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/avj.12694","article-title":"Virus-neutralising antibody responses in horses following vaccination with Equivac(R) HeV: a field study.","volume":"96","author":"Tan","year":"2018","journal-title":"Aust Vet J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1128\/JVI.00263-06","article-title":"Recombinant nipah virus vaccines protect pigs against challenge.","volume":"80","author":"Weingartl","year":"2006","journal-title":"J Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1128\/jvi.78.2.834-840.2004","article-title":"Nipah virus: vaccination and passive protection studies in a hamster model.","volume":"78","author":"Guillaume","year":"2004","journal-title":"J Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis699","article-title":"Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.","volume":"207","author":"Ploquin","year":"2013","journal-title":"J Infect Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2013.10.012","article-title":"Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.","volume":"101","author":"Lo","year":"2014","journal-title":"Antiviral Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3201\/eid2506.181620","article-title":"Use of single-injection recombinant vesicular stomatitis virus vaccine to protect nonhuman primates against lethal nipah virus disease.","volume":"25","author":"Mire","year":"2019","journal-title":"Emerg Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422x-10-353","article-title":"Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.","volume":"10","author":"Mire","year":"2013","journal-title":"Virol J."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0112-x","article-title":"Erratum: Publisher Correction: rabies-based vaccine induces potent immune responses against Nipah virus.","volume":"4","author":"Keshwara","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008929","article-title":"Rabies-based vaccine induces potent immune responses against Nipah virus.","volume":"4","author":"Keshwara","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/JVI.02308-14","article-title":"Rhabdovirus-based vaccine platforms against henipaviruses.","volume":"89","author":"Kurup","year":"2015","journal-title":"J Virol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058414","article-title":"Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.","volume":"8","author":"Yoneda","year":"2013","journal-title":"PLoS One."},{"key":"B75","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/528801","article-title":"Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.","volume":"197","author":"Zhu","year":"2008","journal-title":"J Infect Dis."},{"key":"B76","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.80.2.891-899.2006","article-title":"Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.","volume":"80","author":"Zhu","year":"2006","journal-title":"J Virol."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002901","article-title":"A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.","volume":"3","author":"Bossart","year":"2011","journal-title":"Sci Transl Med."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000642","article-title":"A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.","volume":"5","author":"Bossart","year":"2009","journal-title":"PLoS Pathog."},{"key":"B79","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","article-title":"An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.","volume":"26","author":"Dang","year":"2019","journal-title":"Nat Struct Mol Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements.","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J Struct Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy.","volume":"157","author":"Tang","year":"2007","journal-title":"J Struct Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","article-title":"RELION: implementation of a Bayesian approach to cryo-EM structure determination.","volume":"180","author":"Scheres","year":"2012","journal-title":"J Struct Biol."},{"key":"B83","author":"Yee-Peng","year":"2016","journal-title":"Antibodies Against F Glycoprotein of Hendra and Nipah VIruses."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1517\/14712590902763755","author":"Dimitrov","year":"2011","journal-title":"Human Monoclonal Antibodies Against Hendra and Nipah Viruses."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/bios7040049","article-title":"Strategies using bio-layer interferometry biosensor technology for vaccine research and development.","volume":"7","author":"Petersen","year":"2017","journal-title":"Biosensors (Basel)."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jviromet.2009.02.025","article-title":"Development of a neutralization assay for Nipah virus using pseudotype particles.","volume":"160","author":"Tamin","year":"2009","journal-title":"J Virol Methods."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1128\/JVI.01852-10","article-title":"Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.","volume":"85","author":"Chattopadhyay","year":"2011","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002836","article-title":"Cedar virus: a novel Henipavirus isolated from Australian bats.","volume":"8","author":"Marsh","year":"2012","journal-title":"PLoS Pathog."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008929","article-title":"Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.","volume":"6","author":"Geisbert","year":"2014","journal-title":"Sci Transl Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/viro.2001.1158","article-title":"Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus.","volume":"290","author":"Bossart","year":"2001","journal-title":"Virology."},{"key":"B91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0166-0934(01)00377-9","article-title":"A rapid immune plaque assay for the detection of Hendra and Nipah viruses and anti-virus antibodies.","volume":"99","author":"Crameri","year":"2002","journal-title":"J Virol Methods."},{"key":"B92","first-page":"309","article-title":"Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors.","volume":"269","author":"Bossart","year":"2004","journal-title":"Methods Mol Biol."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00738","article-title":"Structural vaccinology for viral vaccine design.","volume":"10","author":"Anasir","year":"2019","journal-title":"Front Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.sbi.2018.06.002","article-title":"Structure-based immunogen design-leading the way to the new age of precision vaccines.","volume":"51","author":"Sesterhenn","year":"2018","journal-title":"Curr Opin Struct Biol."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaj1879","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.","volume":"1","author":"Gilman","year":"2016","journal-title":"Sci Immunol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01708-9","article-title":"Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein.","volume":"8","author":"Battles","year":"2017","journal-title":"Nat Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein.","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature."},{"key":"B99","doi-asserted-by":"publisher","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B100","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.antiviral.2013.06.012","article-title":"A treatment for and vaccine against the deadly Hendra and Nipah viruses.","volume":"100","author":"Broder","year":"2013","journal-title":"Antiviral Res."},{"key":"B101","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.3","article-title":"Protection from Hendra virus infection with Canarypox recombinant vaccine.","volume":"1","author":"Guillaume-Vasselin","year":"2016","journal-title":"NPJ Vaccines."},{"key":"B102","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1099\/0022-1317-70-10-2637","article-title":"Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein.","author":"Brideau","year":"1989","journal-title":"J Gen Virol."},{"key":"B103","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1016\/j.vaccine.2017.10.095","article-title":"Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.","volume":"35","author":"Garg","year":"2017","journal-title":"Vaccine."},{"key":"B104","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2018.07.021","article-title":"A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.","volume":"158","author":"Garg","year":"2018","journal-title":"Antiviral Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1099\/0022-1317-70-10-2625","article-title":"Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector.","author":"Wathen","year":"1989","journal-title":"J Gen Virol."},{"key":"B106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41590-017-0007-9","article-title":"Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.","volume":"19","author":"Graham","year":"2018","journal-title":"Nat Immunol."},{"key":"B107","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0005-9","article-title":"Protection of calves by a prefusion-stabilized bovine RSV F vaccine.","volume":"2","author":"Zhang","year":"2017","journal-title":"NPJ Vaccines."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:16:42Z","timestamp":1591834602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2020.00842"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00842","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"article-number":"842"}}